{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T09:55:44Z","timestamp":1758448544323,"version":"3.44.0"},"reference-count":11,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.jns.2020.117002","type":"journal-article","created":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T03:04:03Z","timestamp":1592881443000},"page":"117002","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Severe visual loss after one episode of anti-MOG optic neuritis"],"prefix":"10.1016","volume":"416","author":[{"given":"Anna","family":"Kabanovski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trishal","family":"Jeeva-Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward","family":"Margolin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2020.117002_bb0005","series-title":"Neuro-Ophthalmology: Diagnosis and Management","first-page":"205","author":"Liu","year":"2010"},{"key":"10.1016\/j.jns.2020.117002_bb0010","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/1742-2094-8-184","article-title":"Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders","volume":"8","author":"Mader","year":"2011","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jns.2020.117002_bb0015","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ajo.2018.07.020","article-title":"Myelin oligodendrocyte glycoprotein antibody-positive optic neuritis: clinical characteristics, radiologic clues, and outcome","volume":"195","author":"Chen","year":"2018","journal-title":"Am J. Ophthalmol."},{"issue":"6","key":"10.1016\/j.jns.2020.117002_bb0020","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/ICU.0000000000000520","article-title":"Myelin oligodendrocyte glycoprotein-IgG-associated optic neuritis","volume":"29","author":"Chun","year":"2018","journal-title":"Curr. Opin. Ophthalmol."},{"issue":"1","key":"10.1016\/j.jns.2020.117002_bb0025","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s12974-018-1144-2","article-title":"MOG encephalomyelitis: international recommendations on diagnosis and antibody testing","volume":"15","author":"Jarius","year":"2018","journal-title":"J. Neuroinflammation"},{"issue":"12","key":"10.1016\/j.jns.2020.117002_bb0030","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.1093\/brain\/awx276","article-title":"Clinical presentation and prognosis in MOG-antibody disease: a UK study","volume":"140","author":"Jurynczyk","year":"2017","journal-title":"Brain."},{"issue":"1","key":"10.1016\/j.jns.2020.117002_bb0035","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/WNO.0000000000000669","article-title":"Unfavorable structural and functional outcomes in myelin oligodendrocyte glycoprotein antibody\u2013associated optic neuritis","volume":"39","author":"Jelcic","year":"2019","journal-title":"J. Neuroophthalmol."},{"issue":"2","key":"10.1016\/j.jns.2020.117002_bb0040","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1177\/1120672118784797","article-title":"Clinical presentation of optic neuritis with autoantibodies anti-myelin oligodendrocyte glycoprotein","volume":"29","author":"Ducloyer","year":"2019","journal-title":"Eur. J. Ophthalmol."},{"issue":"4","key":"10.1016\/j.jns.2020.117002_bb0045","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1001\/jamaophthalmol.2017.6757","article-title":"Prevalence of myelin oligodendrocyte glycoprotein and aquaporin-4\u2013igg in patients in the optic neuritis treatment trial","volume":"136","author":"Chen","year":"2018","journal-title":"JAMA Ophthalmol."},{"issue":"2","key":"10.1016\/j.jns.2020.117002_bb0050","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1001\/archopht.1995.01100020014004","article-title":"The optic neuritis treatment trial: three-year follow-up results","volume":"113","author":"Beck","year":"1995","journal-title":"Arch. Ophthalmol."},{"issue":"4","key":"10.1016\/j.jns.2020.117002_bb0055","doi-asserted-by":"crossref","first-page":"e572","DOI":"10.1212\/NXI.0000000000000572","article-title":"Does time equal vision in the acute treatment of a cohort of AQP4 and MOG optic neuritis?","volume":"6","author":"Stiebel-Kalish","year":"2019","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X20303397?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X20303397?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T15:52:02Z","timestamp":1758383522000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X20303397"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":11,"alternative-id":["S0022510X20303397"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2020.117002","relation":{},"ISSN":["0022-510X"],"issn-type":[{"type":"print","value":"0022-510X"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Severe visual loss after one episode of anti-MOG optic neuritis","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2020.117002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"117002"}}